Definitive Healthcare Corp. (NASDAQ:DH) Receives Average Recommendation of “Hold” from Analysts

Definitive Healthcare Corp. (NASDAQ:DH) has been assigned a consensus rating of “Hold” from the twelve research firms that are covering the company, Marketbeat reports. Two equities research analysts have rated the stock with a sell recommendation, seven have given a hold recommendation and three have given a buy recommendation to the company. The average 1 year price objective among analysts that have updated their coverage on the stock in the last year is $5.35.

A number of research analysts have recently commented on the company. The Goldman Sachs Group dropped their price objective on Definitive Healthcare from $4.50 to $3.00 and set a “neutral” rating on the stock in a report on Tuesday, March 4th. Barclays dropped their price target on Definitive Healthcare from $4.00 to $3.00 and set an “underweight” rating on the stock in a research report on Monday, March 3rd. Finally, Needham & Company LLC restated a “hold” rating on shares of Definitive Healthcare in a research note on Thursday, January 16th.

Definitive Healthcare Stock Performance

Definitive Healthcare stock opened at $2.84 on Friday. The firm has a 50 day simple moving average of $2.79 and a 200-day simple moving average of $3.93. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.49 and a quick ratio of 2.49. The stock has a market cap of $306.61 million, a price-to-earnings ratio of -0.92, a price-to-earnings-growth ratio of 4.06 and a beta of 1.48. Definitive Healthcare has a 1-year low of $2.15 and a 1-year high of $7.47.

Definitive Healthcare (NASDAQ:DH) last posted its quarterly earnings data on Thursday, February 27th. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.07 by ($0.04). Definitive Healthcare had a negative net margin of 142.38% and a positive return on equity of 1.76%. The firm had revenue of $62.29 million during the quarter, compared to analysts’ expectations of $60.60 million. On average, analysts expect that Definitive Healthcare will post 0.16 EPS for the current year.

Hedge Funds Weigh In On Definitive Healthcare

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Hennion & Walsh Asset Management Inc. increased its position in Definitive Healthcare by 34.1% in the 4th quarter. Hennion & Walsh Asset Management Inc. now owns 50,886 shares of the company’s stock worth $209,000 after buying an additional 12,946 shares during the period. JPMorgan Chase & Co. lifted its position in Definitive Healthcare by 431.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 222,090 shares of the company’s stock worth $993,000 after buying an additional 180,323 shares in the last quarter. Barclays PLC grew its stake in shares of Definitive Healthcare by 318.8% during the third quarter. Barclays PLC now owns 81,916 shares of the company’s stock valued at $366,000 after purchasing an additional 62,354 shares during the last quarter. Quantbot Technologies LP increased its stake in shares of Definitive Healthcare by 5,305.5% in the 4th quarter. Quantbot Technologies LP now owns 17,730 shares of the company’s stock valued at $73,000 after buying an additional 17,402 shares during the period. Finally, Bank of New York Mellon Corp grew its position in shares of Definitive Healthcare by 35.9% during the 4th quarter. Bank of New York Mellon Corp now owns 229,143 shares of the company’s stock worth $942,000 after buying an additional 60,559 shares during the period. Institutional investors and hedge funds own 98.67% of the company’s stock.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.